After PGT-A
Use the PGT-A data you already have to check every embryo for genes tied to infertility and pregnancy loss—without another biopsy.
We confirm your data is compatible before you pay
Both partners screened across 750+ genes, then every finding checked in each of your embryos.
$750
No reportable finding? Full refund. Available only when the completed report has no qualifying result under the published product terms.
Results are informational and do not diagnose a condition, explain every pregnancy loss, recommend treatment, or guarantee an outcome.
Payment options through Affirm are subject to eligibility and may require a down payment.
No new biopsy
Counselor review
Pay over time
~1 in 4couples with unexplained, chromosomally normal loss carried a single-gene cause — findable in the parents, checkable in every embryo.
Aminbeidokhti et al., medRxiv 2025 (preprint): 30 of 118 families with two or more unexplained losses; 25 of the 30 inherited.
What happens next
No new biopsy, and a counselor walks you through the result.
Step 01
We ship two saliva kits. Send them back, and we screen both of you across 750+ genes.
Step 02
Your embryos’ existing PGT-A data, read against both partners’ genomes, shows which viability genes each embryo inherited.
Viability & pregnancy-loss genes
E4
None
E2
F5
E7
TUBB8
E6
TUBB8
E5
None
A gene variant is either there or it isn't — no scores, no percentiles.
Step 03
A genetic counselor goes through each embryo’s findings with you — what was found, and what it does and doesn’t mean.
Sample report
The genes tied to infertility and pregnancy loss, reported beside the chromosome result you already have.
Embryo report · comparison
| Embryo | Chromosomes | Viability genes |
|---|---|---|
| Embryo 44AA · Day 5 | Euploid | No known risks |
| Embryo 25AB · Day 5 | Euploid | Moderate risk |
| Embryo 75BA · Day 5 | Euploid | Higher risk |
| Embryo 64BA · Day 5 | Low-level mosaic | Higher risk |
| Embryo 53BB · Day 6 | Aneuploid | Higher risk |
Takeaway
Three of the five are euploid — only Embryo 4 with no reportable gene finding.
Embryo report · detail
TUBB8
Establishedc.686T>C (p.Val229Ala) · Maternal-effect
Published pathogenic variant linked to oocyte maturation defect and early embryo arrest.
Context
Chromosomally normal, and still a finding — a chromosome count cannot see this.
Also found: F5 in Embryo 2 — limited-evidence, lower relevance.
Embryo report · counselor
Christina's counselor note
Reviewed by Christina, Genetic Counselor
Embryo 7 is chromosomally normal but carries a TUBB8 variant tied to early embryo arrest.
Next
We go through this with you, then you take it to your care team with your questions ready.
Decision support for you and your care team — not a transfer decision.
Illustrative example. Your findings and recommendations will depend on your results and clinical history.
Core reports chromosomes and viability genes — no polygenic scores, no trait predictions. Complete adds 24+ health conditions and traits for $1,000.
Both partners are screened across the full 750+ gene Infertility & Pregnancy Loss Panel, and anything found there is checked in each of your embryos.
Evidence and boundaries
How gene screening differs from chromosome testing and carrier screening.
Common questions
Core reads the PGT-A data your embryos already have, alongside both partners' 750+ gene screen, and reports each embryo's chromosome result with a viability-gene review. Genetic counseling is included.
No new biopsy or test is needed — we use the PGT-A data from your already-tested embryos. Compatibility depends on how your embryos were sequenced, so we review your files and confirm before you pay anything for embryo analysis.
PGT-A platforms read markers scattered across each embryo's genome. With both partners sequenced, those markers show which parental copies each embryo inherited — so a variant found in a parent can be checked in every embryo, with nothing new taken from them.
We'll work with you to get your embryo data into a usable form wherever we can. And the Infertility & Pregnancy Loss Panel is available to everyone, for one or both partners, whether or not we can offer embryo analysis.
Core focuses on pregnancy-loss and fertility findings. Complete includes everything in Core, then adds 24+ health conditions and traits for every embryo, with downloadable data.
No. Reticular reports are informational and meant to support conversations with your physician and genetic counselor. Your care team remains responsible for medical recommendations, and the reproductive choices are always yours. Reticular does not diagnose conditions or guarantee health outcomes.
It means the review found no reportable finding under current methods and evidence standards. It does not rule out every genetic factor or guarantee that a transfer will succeed. An eligible order with no qualifying result in either partner can request a full refund under the No-Finding Promise.
Yes. A genetic counselor helps place the report in context, explains what a finding does and does not mean, and helps you prepare questions for your fertility clinician or other care team.
A human next step
Text us a quick question, or book a free conversation with Christina, our licensed genetic counselor, about your embryo data, your prior testing, and whether Core fits.
The Infertility & Pregnancy Loss Panel screens both partners from an at-home saliva sample — no IVF needed to start.